4//SEC Filing
Jounce Therapeutics, Inc. 4
Accession 0001104659-17-006178
CIK 0001640455operating
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:03 PM ET
Size
4.4 KB
Accession
0001104659-17-006178
Insider Transaction Report
Form 4
Higgons John Duncan
Director
Transactions
- Purchase
Common Stock
2017-02-01$16.00/sh+6,700$107,200→ 27,025 total
Documents
Issuer
Jounce Therapeutics, Inc.
CIK 0001640455
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001640455
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:03 PM ET
- Size
- 4.4 KB